BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  radionuclide: 2, labeled: 8     
HTML
53%
YM BioSciences, University of Toronto Update On Development Of Radionuclide-Conjugated Antibody Molecule
YM BioSciences has announced results of a collaboration with researchers at the University of Toronto, for the development of highly potent antibody-radionuclide conjugates for the treatment of cancer.

The approach has successfully concluded its first series...

Pharmaceutical Business Review:  Jan 12 2010 4:51PM
Matching: radionuclide 		Find similar documents
HTML
53%
YM teams with U of T to develop cancer treatment
James Smith reports YM BIOSCIENCES ANNOUNCES COLLABORATION WITH UNIVERSITY OF TORONTO FOCUSED ON DEVELOPMENT OF NOVEL RADIONUCLIDE-CONJUGATED ANTIBODY MOLECULE Collaboration utilizes antibodies selectively targeting cancer cells combined with nuclear...
Stockwatch:  Jan 11 2010 2:25PM
Matching: radionuclide 		Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.